UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Alimentary pharmacology & therapeutics, ISSN 0269-2813, 10/2020, Volume 52, Issue 7, pp. 1195 - 1203
Journal Article
Gut, ISSN 0017-5749, 11/2015, Volume 64, Issue 11, pp. 1810 - 1815
Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Pregnancy Complications, Infectious - virology | Prognosis | Prospective Studies | Puerperal Disorders - blood | Humans | Symptom Flare Up | Hepatitis B, Chronic - virology | Pregnancy | Pregnancy Complications, Infectious - blood | Adult | Female | Hepatitis B, Chronic - blood | Puerperal Disorders - virology | Care and treatment | Immune response | Research | Biological markers | Analysis | Hepatitis B | Antigens | Postpartum period | Mortality | Infections | Inflammation | Studies | Hepatitis | Infectious diseases | Immunology | Womens health | Deoxyribonucleic acid--DNA | Immune system | Index Medicus | Abridged Index Medicus
Journal Article
3.
Full Text
Treatment decisions in multiple sclerosis-insights from real-world observational studies
Nature reviews. Neurology, ISSN 1759-4758, 02/2017, Volume 13, Issue 2, pp. 105 - 118
Journal Article
Multiple sclerosis, ISSN 1352-4585, 7/2018, Volume 24, Issue 8, pp. 1087 - 1095
Rituximab | propensity score matching | disability progression | treatment persistence | relapse | Multiple Sclerosis, Relapsing-Remitting - drug therapy | Humans | Middle Aged | Male | Treatment Outcome | Disease Progression | Interferon-beta - therapeutic use | Rituximab - therapeutic use | Sweden | Glatiramer Acetate - therapeutic use | Adult | Female | Registries | Immunologic Factors - therapeutic use | Multiple sclerosis | Interferon | Copolymer 1 | β-Interferon | Patients | Index Medicus | Medicin och hälsovetenskap
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 1/2012, Volume 54, Issue 1, pp. 43 - 50
Statistical median | T lymphocytes | Human T lymphotropic virus 1 | Health outcomes | Childhood | Viruses | Bronchiectasis | Infections | Adults | Computerized axial tomography | ARTICLES AND COMMENTARIES | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Biological and medical sciences | Infectious diseases | Medical sciences | Respiratory system : syndromes and miscellaneous diseases | Pneumology | Humans | Middle Aged | Risk Factors | Child, Preschool | Infant | Male | Treatment Outcome | Bronchiectasis - mortality | Bronchiectasis - pathology | Bronchiectasis - epidemiology | Survival Analysis | Adult | Female | Human T-lymphotropic virus 1 - pathogenicity | Population Groups | Retrospective Studies | Australia | Child | HTLV-I Infections - complications | Cohort Studies | Research | Patient outcomes | Risk factors | HTLV-I (Virus) | Native peoples | Clinical medicine | Lung diseases | Mortality | Viral infections | Clinical outcomes | Index Medicus
Journal Article
Substance use & misuse, ISSN 1082-6084, 02/2018, Volume 53, Issue 3, pp. 457 - 465
health resources | emergency service | cohort | Australia | hospital | injecting drug use | longitudinal studies | Social Sciences | Life Sciences & Biomedicine | Substance Abuse | Psychiatry | Psychology | Science & Technology | Drug abuse | Modification | Disease | Mental disorders | Referrals | Accident and emergency departments | Medical diagnosis | Externality | Presentations | Confidence intervals | Medical referrals | Classification | Mental health services | Injuries | Emergency medical services | Drug use | Medical treatment | Social services | Patients | Cohort analysis | Characteristics | Intravenous drug addicts | Emergency services | Support services | Poisoning | Social support | Index Medicus
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 04/2019, Volume 321, Issue 14, pp. 1380 - 1390
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | HIV Infections - prevention & control | Emtricitabine - therapeutic use | Tenofovir - therapeutic use | Humans | Middle Aged | Proportional Hazards Models | Male | Sexually Transmitted Diseases - epidemiology | Bisexuality | Australia - epidemiology | Incidence | Pre-Exposure Prophylaxis | Young Adult | Unsafe Sex - statistics & numerical data | Homosexuality, Male | Adolescent | Adult | Anti-HIV Agents - therapeutic use | Drug Therapy, Combination | Population Surveillance | Health care | Sexually transmitted diseases--STD | Prophylaxis | Infections | Males | Risk factors | Tenofovir | Chlamydia | Mathematical analysis | Syphilis | Human immunodeficiency virus--HIV | Emtricitabine | Bisexual | Adjustment | Enrollments | Health risks | Data processing | Exposure | Gonorrhea | Risk taking | Risk analysis | Men | Gays & lesbians
Journal Article
The Journal of arthroplasty, ISSN 0883-5403, 11/2020, Volume 35, Issue 11, pp. 3420 - 3423
Journal Article
Frontiers in immunology, ISSN 1664-3224, 11/2018, Volume 9, pp. 2706 - 2706
Pregnancy-related outcomes | Teriflunomide | Pregnancy-related outcomes for mother | Child | Teriflunomide treated men and women | Nationwide Danish register study | Life Sciences & Biomedicine | Immunology | Science & Technology | Treatment outcome | Multiple sclerosis | Pregnant women | Analysis | Diagnosis | Drug therapy | Health aspects | teriflunomide | pregnancy-related outcomes | teriflunomide treated men and women | nationwide Danish register study | pregnancy-related outcomes for mother and child
Journal Article
10.
Full Text
Switch to Natalizumab versus Fingolimod in Active Relapsing-Remitting Multiple Sclerosis
Annals of neurology, ISSN 0364-5134, 03/2015, Volume 77, Issue 3, pp. 425 - 435
Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Disability Evaluation | Propylene Glycols - pharmacology | Severity of Illness Index | Recurrence | Natalizumab | Multiple Sclerosis, Relapsing-Remitting - drug therapy | Humans | Middle Aged | Fingolimod Hydrochloride | Male | Treatment Outcome | Disease Progression | Sphingosine - pharmacology | Sphingosine - analogs & derivatives | Antibodies, Monoclonal, Humanized - administration & dosage | Sphingosine - administration & dosage | Propylene Glycols - administration & dosage | Antibodies, Monoclonal, Humanized - pharmacology | Adult | Female | Registries | Immunosuppressive Agents - pharmacology | Immunosuppressive Agents - administration & dosage | Multiple sclerosis | Interferon | Index Medicus
Journal Article
Obesity surgery, ISSN 0960-8923, 4/2018, Volume 28, Issue 4, pp. 1098 - 1108
Hospital data | Health outcomes | Medicine & Public Health | Surgery | Bariatric surgery | England | Morbid obesity | Length of stay | Life Sciences & Biomedicine | Science & Technology | Type 2 diabetes | Medical research | Obesity | Safety and security measures | Comorbidity | Analysis | Patient outcomes | Medicine, Experimental | Surgical outcomes | Gastrointestinal surgery | Mortality | Index Medicus | Original Contributions | Medicin och hälsovetenskap
Journal Article